As the outcomes of patients with congenital heart disease (CHD) improve, the number of
patients is accumulating and the proportion of adult CHD patients is gradually increasing …

Congenital heart disease (CHD) is the most frequent disorder encountered in the newborn
period and the most frequent cause of infant mortality [1]. It comprises 0.8–1.2% of all live …

Congenital heart defects (CHDs) affect approximately 1% of live births and are a major
source of childhood morbidity and mortality even in countries with advanced healthcare …

Clinical research in the treatment of patients with congenital heart disease (CHD) is limited
by the wide variety of CHD manifestations and therapeutic options as well as the generally …

Like every other prevalent disease process, cardiovascular diseases pose a great risk for
the morbidity and mortality of human beings. Pediatric cardiovascular disease (CVD) …

ABSTRACT Introduction: Mobile health (mHealth), an advanced form of eHealth is expected
to drastically change the field of traditional healthcare in the near future as wearables and …

Advances in congenital heart disease (CHD) have changed radically the prognosis and
burden of the disease. The vast majority of patients survive into adulthood and their profile in …

Congenital heart disease is the most frequently occurring congenital disorder affecting≈
0.8% of live births. Thanks to great efforts and technical improvements, including the …

We are delighted to join and work with the New EHJ Editorial Board representing the most
common and global inborn congenital defect. Congenital heart disease (CHD) has come a …

The care of patients with congenital heart disease has evolved over the past half century
largely through an iterative paradigm combining creative innovations and astute …